-
A Toilet for India That Also Delivers Clean Water
In India, 600 million people lack access to a clean toilet, and, lately, the government has been on a big drive to build more of them. Prime Minister Narendra Modi’s "Clean India" campaign aims to provide decent sanitation to all Indians by 2019.
- Categories
- Health Care
- Region
- South Asia
-
Nigeria: Vaccine Bill to Hit U.S. $345 Million as Donor Support Vanishes
The National Primary Health Care Development Agency (NPHCDA) says government spending on immunisation is expected to top $345 million a year by 2022 when international funding support from the Global Alliance for Vaccine Initiative (GAVI) is completely withdrawn.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
No Radiotherapy, No MRI, No Money: Uganda’s Health Funding Crisis
Monday 11 April was not a normal day in the radiotherapy clinic at the Mulago National Referral hospital in Kampala.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Weekly Roundup: Healthy Debate and Unhealthy Economics at Unite for Sight
I went to a global health conference last weekend and an economics lesson broke out. OK, that’s a bit of an oversimplification. A lot more than economics was discussed at the 13th annual Unite for Sight Global Health & Innovation Conference at Yale University. It’s just that as I scurried from session to session around the campus, I kept hearing about the scarcity and/or misapplication of money.
- Categories
- Health Care, Impact Assessment
- Tags
- public health
-
J&J Ebola Vaccine Has Promise as Wider Test Awaits Next Outbreak
An experimental Ebola vaccine from Johnson & Johnson, boosted by a second immunization shot from biotechnology company Bavarian Nordic A/S, generated a powerful immune response among volunteers in its first tests in humans.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
‘India Makes All Mylan HIV Drugs for Developing World’
Rajiv Malik is president of Mylan, the $9.5-billion, Nasdaq-listed global generic and speciality pharmaceuticals company. Malik became part of Mylan in 2007 when the latter acquired India-based Matrix Laboratories, where he was CEO. That deal also transformed Mylan, which till then operated only in the US, into one of the world's largest manufacturers of active pharmaceutical ingredients (APIs). On a recent visit to Bengaluru, Malik spoke to TOI:
- Categories
- Health Care
- Region
- South Asia
-
A New Blood Test for Tuberculosis Could Save Millions of Lives
As much as one third of the global population is currently infected with the bacterium that causes tuberculosis (TB), a disease typically concentrated in the lungs and characterized by weakness, fever, coughing and chest pain. About 9.6 million new infections occurred in 2014, the most recent year for which numbers are available. Roughly 1.5 million people died of TB that same year. The ability to easily, inexpensively and accurately diagnose TB is of utmost importance, but the most commonly used method fails, at least to some extent, on all three counts. A new blood-based technique might considerably rein in this epidemic.
- Categories
- Health Care
- Region
- South Asia
-
1mg Gets $16 Million Series B to Make India’s Health Industry More Transparent
India’s pharmaceutical market is filled with generic options—but they don’t always save consumers money. In fact, some drugs are even more expensive than their branded counterparts. Created to give patients more power over their health costs, startup 1mg announced today that it has raised a $16 million Series B led by Maverick Capital Ventures, with participation from returning investors Sequoia India and Omidiyar Network.
- Categories
- Health Care
- Region
- South Asia
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.